Study title: The effect on refractive error of unilateral atropine as compared with patching for the treatment of amblyopia. Repka MX, Melia M, Eibschitz-Tsimhoni M, London R, Magoon E; Pediatric Eye Disease Investigator Group. J AAPOS. 2007 Jun;11(3):300-2.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Eye Diseases [C11] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: ATROPINE | |||||
| ATC code: | |||||
| Document link: The effect on refractive error of unilateral atropine.pdf | |||||
| Document date: 2011-09-13 | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |